KIMBERLY MCPHERSON: Open Payments
NPI 1558991919 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 81 payments from 21 companies in 2025. Trend: 2023 $2,021 · 2024 $2,066 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $283 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $179 |
| Amgen Inc. | 17 | $150 |
| Phathom Pharmaceuticals, Inc. | 6 | $79 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Novo Nordisk Inc | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| PFIZER INC. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
Products named: XIFAXAN, VRAYLAR, OTEZLA, VOQUEZNA, Auvelity, JARDIANCE, NURTEC ODT, CAPLYTA.
Industry payments across NC — which companies pay providers there.
